EnVivo is a biopharmaceutical company dedicated to discovering and developing drugs for central nervous system (CNS) disorders, currently focusing on Alzheimer?s disease, and ...
http://ENVIVOPHARMACEUTICALS.COM
Vivo Ventures is a life-sciences focused venture capital firm formed in 1996 with ... public biotechnology companies in the areas of biopharmaceuticals, specialty pharmaceuticals ...
http://www.vivoventures.com/
Ore Pharmaceuticals has developed a state-of-the-art imaging program that allows the pharmacological action of a drug to be visualized non-invasively throughout an entire mouse.
http://www.orepharma.com/in-vivo-imaging
Avanir Pharmaceuticals (NASDAQ: AVNR) is focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.
http://www.vivoventures.com/portfolio.html
View job summary for Scientist, in vivo DMPK at Synta Pharmaceuticals in Lexington, MA. Job search made simple at SimplyHired, the largest search engine for jobs.
http://www.simplyhired.com/job-id/hpvvkcu6pl/scientist-in-jobs/
No. 3 Sooners make BCS case; beat Cowboys 61-41 Golf: Japan LPGA money rankings+ Golf: ... All: u.s. world: politics: business: sports: entertainment: sci/tech: health: odd: video ...
http://www.breitbart.com/?id=prnw.20070129.UKM014&show_article=1&cat=hlth
In vivo and job search made simple at SimplyHired, the largest search engine for jobs ... Synta Pharmaceuticals - Lexington, MA
http://www.simplyhired.com/a/jobs/list/q-In+vivo+and/l-Cambridge%2C+MA
Silicon Valley news about tech money and innovation ... Vivo Ventures plans its first in Asian life-science investments now that it has closed a new fund, VentureWire is reporting ...
http://venturebeat.com/tag/coaspreva-pharmaceuticals/
Palo Alto, CA October 24, 2007 Vivo Ventures. APT Pharmaceuticals Closes New $22 Million Funding Round Burlingame, CA - October 4, 2007. Sagent Pharmaceuticals Inc.
http://www.bioasia.com/about.html
APT Pharmaceuticals Adds Vivo Ventures in Final Close of $9 Million First Round. Vivo Ventures participated in the final close of a $9 million ...
http://www.aptbio.com/n_032106.html
In this highly challenging role you will be responsible for the implementation of in vivo assays that will be used for the assessment of compounds in rodents to support drug ...
http://www.addexpharma.com/careers/non-clinical-development/technician-in-vivo-ncds/
To support the growing R&D pipeline, there is a need to recruit additional toxicologists to join NCD. In this role, you will be responsible for the delivery of the non-clinical ...
http://www.addexpharma.com/careers/non-clinical-development/laboratory-head-in-vivo/
APT Pharmaceuticals Adds Vivo Ventures in Final Close of $9 Million First Round : MEDIA COVERAGE
http://www.aptbio.com/n_100407.html
TeeleOstin Pharmaceuticals has tested the activity of fish PTH using both in vitro and in vivo assays. In vitro Assays . The adenylate cyclase bioassay was used to test fPTH in ...
http://www.teeleostin.com/technology.htm
... company, offering our clients discovery and development services for in vivo testing. ... Phil spent the last 3 years leading the Preclinical Research team at Sirtris Pharmaceuticals.
http://www.vivopath.com/aboutvivopath.html
Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company today announced the closing of a $53 million Series A financing led by Vivo Ventures.
http://www.sagentpharma.com/content/view/1/106/
LENEXA, Kan., Oct 27, 2008 (BUSINESS WIRE) -- VasoGenix Pharmaceuticals Inc. announced today that preclinical in vivo screening of a series of synthetic analogs of calcitonin gene ...
http://vasogenix.net
Home Page description ... AVEO has built a pipeline of proprietary inducible in vivo cancer models for Target Discovery and Human Response Prediction.
http://www.aveopharma.com/content/index.jsp
Biography: Since 2004, Dr. Foley has been Director of In Vivo Pharmacology at Synta Pharmaceuticals, a ~170 employee Boston-area pharmaceutical company, where his research focuses ...
http://myprofile.cos.com/kpfoley
Confidential and Proprietary Information of GenPath Pharmaceuticals, Inc. In vivo Genetic Approaches to Identify Mechanisms of Resistance to Inhibition of the HER2 Receptor ...
http://www.aveopharma.com/servlet/DownloadServlet?id=4733 |
|
